To include your compound in the COVID-19 Resource Center, submit it here.

Group identifies S6K1 as potential target for CNS injury

In a paper published in the Journal of Neuroscience, researchers at the University of Miami Miller School of Medicine and colleagues showed that targeting ribosomal protein

Read the full 264 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE